SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

UnitedHealth Group, Inc. engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum's capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience. The OptumHealth segment provides health and wellness care, serving the broad health care marketplace including payers, care providers, employers, government, life sciences companies, and consumers. The OptumInsight segment focuses on data and analytics, technology, and information to help major participants in the healthcare industry. The OptumRx segment offers pharmacy care services. The company was founded by Richard T. Burke in January 1977 and is headquartered in Eden Prairie, MN.

Unitedhealth Group Inc

UnitedHealth Group is trending following a proposed flat rate for Medicare Advantage payments in 2027 by the Trump administration, dramatically below industry expectations. This news, surfacing just before its earnings report, triggered a significant sell-off across the healthcare sector, with the community divided between panicked investors and those eyeing the dip as a prime buying opportunity. Many anticipate future negotiations or a rebound, viewing the sharp drop as an overreaction or market manipulation.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth Inc. is trending after securing a proposed $1.6 billion U.S. government investment and an additional $1.5 billion in private capital, aimed at bolstering the domestic rare earth supply chain. The community is actively discussing this substantial funding, with many anticipating a major re-rating for the pre-revenue company, while others debate potential market manipulation and the impact of new share issuance. This strategic support is viewed as crucial for establishing a U.S. mine-to-magnet infrastructure and reducing foreign dependency on critical minerals.

BlackRock Institutional Trust Company N.A. - iShares Silver Trust

iShares Silver Trust

iShares Silver Trust (SLV) is experiencing extreme volatility after a dramatic price surge, fueled by strong industrial demand for silver in emerging technologies and significant purchasing activity from Asia. The community is fiercely divided, with many celebrating monumental gains and predicting further ascent due to historical undervaluation and supply constraints, while others warn of an unsustainable bubble and potential market manipulation following sharp intraday price swings.

GameStop Corp. engages in offering games and entertainment products through its ecommerce properties and stores. The firm’s stores and ecommerce sites operate primarily under the names GameStop, EB Games, and Micromania. It operates through the following geographical segments: United States, Canada, Australia, and Europe. The company was founded by Daniel A. DeMatteo in 1996 and is headquartered in Grapevine, TX.

Gamestop Corporation - Ordinary Shares - Class A

GameStop Corp

GameStop is heavily trending after famed investor Michael Burry disclosed a new long-term position, amplifying recent insider buys by CEO Ryan Cohen and other directors. The community is buzzing with speculation, drawing parallels to past events and debating whether these significant purchases signal a true resurgence or simply a short-term rally. Many are eagerly anticipating further catalysts, including potential gamma squeezes and the symbolic return of key figures.

Humana Inc. engages in the provision of health insurance services. It operates through the Insurance and CenterWell segments. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as contract with CMS to administer the Limited Income Newly Eligible Transition, or LI-NET, prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits, which refer to as state-based contracts. The CenterWell segment represents payor-agnostic healthcare services offerings, including pharmacy dispensing services, provider services, and home services. The company was founded by David A. Jones, Sr., and Wendell Cherry on August 18, 1961 and is headquartered in Louisville, KY.

Humana Inc.

Humana Inc

Humana is actively discussed after recent proposals for flat Medicare Advantage payment rates and a reported lawsuit loss challenging past bonus cuts sparked significant volatility in the stock. The community remains divided, with many seeing current valuations as a compelling buying opportunity amid broader concerns about government policy and rising costs impacting the healthcare insurance sector.

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

The immediate catalyst driving conversations around CVS Health is the proposed essentially flat Medicare Advantage payment rates for 2027 by CMS, significantly below market expectations. This development is broadly perceived as a policy-driven margin squeeze risk for the healthcare sector, with the community actively discussing potential prolonged multiple compression and de-risking across MA-heavy insurers.

NetEase, Inc. is an internet technology company, which engages in the provision of premium online services centered around content, community, communication and commerce. It develops and operates some of the most popular PC-client and mobile games in China. The firm also operates some of the most popular international online games in China by partnering with Blizzard Entertainment, Mojang AB (a Microsoft subsidiary) and other global game developers. NetEase also offers other services, including the intelligent learning services of its majority-controlled subsidiary, Youdao, its music streaming platform, NetEase Cloud Music, and its private label e-commerce platform, Yanxuan. The company operates through the following business segments: Online Game Services, Youdao, Cloud Music, and Innovative Businesses and Others. The Online Game Services segment produces online PC-client games. The Youdao segment is an online education service provider in China. The Cloud Music segment represents revenue from online music services through the sales of membership subscriptions in various content and service packages. The Innovative Businesses and Others segment offers other services, which includes live video streaming and its private label e-commerce platform, Yanxuan. The company was founded by Lei Ding in June 1997 and is headquartered in Beijing, China.

NetEase Inc - ADR

NetEase.com, Inc.

NetEase is trending strongly as community excitement builds around its robust game pipeline, featuring anticipated titles like Marvel Rivals, following solid earnings reports. Investor confidence is significantly buoyed by the substantial easing of regulatory concerns within the Chinese gaming sector and a renewed publishing agreement with Blizzard Entertainment. This strategic positioning and improving market environment are key discussion points.

Climb Global Solutions, Inc. engages in the distribution of software developed by others through resellers indirectly to customers. It operates through the Distribution and Solutions segments. The Distribution segment distributes technical software to corporate resellers, value added resellers (VARs), consultants and systems integrators worldwide under the names Climb Channel Solutions and Sigma Software Distribution. The Solutions segment provides cloud solutions and value-added reseller of software, hardware, and services to customers worldwide under the names TechXtend and Grey Matter. The company was founded by Edwin Huffman Morgens in 1982 and is headquartered in Eatontown, NJ.

Climb Global Solutions Inc

Climb Global Solutions (CLMB) is trending following impressive financial results and a notable analyst upgrade to Outperform, highlighting strong year-over-year growth in net sales and gross profits. The company's strategic focus on value-added IT distribution in high-demand areas like cybersecurity and cloud solutions resonates with investors, who view it as a high-growth, under-the-radar gem despite its typically low trading volume.

SPDR Gold Trust - SPDR Gold Shares

SPDR Gold Shares ETF

GLD is experiencing a historic surge to new highs, primarily fueled by ongoing geopolitical tensions and significant buying interest from central banks and institutional investors. Community discussions reflect a polarized view, with many hailing gold as a critical safe-haven and inflation hedge, while others express caution about its parabolic climb and potential for a sharp correction amidst a weakening dollar backdrop.

Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.

Elevance Health Inc

Elevance Health is navigating market volatility as the healthcare sector responds to concerns over future Medicare payment rates and the ongoing debate surrounding Affordable Care Act subsidies. Despite ELV recently exceeding adjusted earnings expectations, community sentiment is divided between those viewing current valuations and strategic shifts as a compelling opportunity and those remaining cautious about broader industry headwinds and margin pressures.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Regencell Bioscience Holdings Ltd (3,500% Jump in Message Volume)Hong Kong-based Regencell focuses on traditional Chinese medicine for neurocognitive disorders, particularly ADHD and autism. Reports suggest its recent rally was fueled by insider buying, with insiders owning 81% of the company.&nbsp;However, a Stocktwits&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rgc-stock-more-than-triples-this-year/ch7KEpeRbcl">poll</a> indicates retail traders remain skeptical, with some flagging it as a potential pump-and-dump risk.&nbsp;The stock has surged 1,054% this year.GlucoTrack Inc. (2,800% Jump in Message Volume)GlucoTrack develops non-invasive glucose monitoring devices. It announced that safety and performance data from its first-in-human trial of a long-term continuous blood glucose monitoring (CBGM) system will be presented at the 2025 ATTD conference.&nbsp;CEO Paul V. Goode highlighted its potential for real-time glucose monitoring without on-body wearables, calling it a transformative step in diabetes management.&nbsp;GlucoTrack stock is down over 96% year-to-date (YTD).TC Biopharm (Holdings) Plc (1,300% Jump in Message Volume)TC Biopharm&nbsp;<a href="https://stocktwits.com/symbol/TCBP">received</a> a Nasdaq delisting notice due to its share price falling below $1. Trading will be suspended on Monday, with its American depository shares expected to move to OTC Markets.&nbsp;The company is also shifting to a contract development and manufacturing organization (CDMO) model, cutting about 50% of its workforce to reduce operational burn by 55%. This is projected to save $2.1 million in 2025 and $4.2 million annually.&nbsp;The stock is down over 95% YTD.AbbVie Inc. (700% Jump in Message Volume)Erste Group upgraded AbbVie to ‘Buy’ from ‘Hold’, according to The Fly, citing strong sales growth projections through 2029, supported by upcoming product launches. The research firm expects earnings per share (EPS) to rise significantly in 2025, ranging from $12.12 to $12.32.&nbsp;AbbVie recently agreed to acquire a next-gen obesity drug from Denmark-based Gubra A/S for up to $2.2 billion, boosting sentiment.&nbsp;The stock is up over 17.5% YTD.Actinium Pharmaceuticals Inc. (600% Jump in Message Volume)Actinium is launching trials for its drug Actimab-A in combination with Merck’s Keytruda and Bristol Myers Squibb’s Opdivo to treat solid tumors. The trials will include head-to-head studies comparing Actimab-A combinations to standalone treatments.&nbsp;The company also entered a research agreement with Memorial Sloan Kettering to expand Actimab-A’s applications.&nbsp;Actinium stock is up over 22% YTD.For updates and corrections, email newsroom[at]stocktwits[dot]com.

A person examines financial data on a screen displaying a graph with upward and downward trends, using a pen to trace the line chart. | Representative Image: Getty Images

Regencell, GlucoTrack, TC Biopharm, AbbVie, Actinium: 5 Health Care Stocks That Lit Up Retail Discussions Last Week

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.

Equity

Investors reacted to insider buying, clinical trial updates, and strategic business shifts that happened in the week ended March 21, 2025.


Nasdaq-listed shares of UK-based TC BioPharm (Holdings) PLC (TCBP) tumbled 64% by Friday afternoon after the biopharmaceutical company <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tcbp-announces-transition-from-nasdaq-to-otc-markets-302408102.html">said</a> its securities would be delisted from the exchange.The delisting follows the company’s failure to maintain a minimum bid price of $1 per share. The company said that its management is working on an appeal with Nasdaq and expressed optimism that its American Depositary Shares will be eligible to trade on the OTC markets starting Monday.Earlier this week, the company announced a reduction in its workforce and other measures aimed at reducing core operational burn by 55% compared to last year. The layoff impacted approximately 20 employees, or <a target="_blank" rel="noopener noreferrer nofollow" href="https://ir.tcbiopharm.com/news/press-releases/detail/122/tcbp-announces-outsourcing-initiatives-reducing-burn-rate">half of the company’s total headcount</a>.On Stocktwits, investors expressed frustration over the news.&nbsp;<stembedurl>https://stocktwits.com/Blackdog111/message/608838652</stembedurl>One user opined that there is little chance for recovery for the company’s stock.<stembedurl>https://stocktwits.com/Oxinternet/message/608832026</stembedurl>In early March, TC BioPharm announced that it had executed a non-binding letter of intent to acquire 100% of a commercial-stage ophthalmic pharmaceutical company in an all-stock transaction.CEO Bryan Kobel said the firm expects to execute the binding letter of intent in a few weeks and close the acquisition around the third quarter of this year.At the beginning of 2025, Kobel <a target="_blank" rel="noopener noreferrer nofollow" href="https://www.prnewswire.com/news-releases/tcbp-issues-25-stock-dividend-302340235.html">said</a> he anticipated 2025 to be a “period of growth and development” for the company. He expressed “strong confidence” in the company’s financial future after issuing a special dividend of 0.25 &nbsp;American Depositary Shares (ADSs) for every ADS held by shareholders.&nbsp;The stock has dropped by over 94% this year, wiping nearly all its value over the past twelve months.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/rio-tinto-eyes-bigger-us-footprint-amid-copper-price-surge-fueled-by-trump-tariffs/ch7oTeGRb53">Rio Tinto Reportedly Eyes Bigger US Footprint Amid Copper Price Surge Fueled By Trump Tariffs – Stock Drops, Retail Sentiment Weakens</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Generic picture shows a hand holidng a capsule on 25 July 2004. AFR Picture by LOUIE DOUVIS (Photo by Fairfax Media via Getty Images)

TC BioPharm Stock Crashes On Nasdaq Delisting: Retail Expresses Frustration

The company said that its management is working on an appeal with Nasdaq and expressed optimism that its American Depositary Shares will be eligible to trade on the OTC markets starting Monday.

TC Biopharm (Holdings) Plc is a clinical-stage biopharmaceutical company, which engages in the development of novel immunotherapy products based on its proprietary allogeneic gamma delta T cell platform. The company was founded by Michael Leek and Angela Scott in 2013 and is headquartered in Motherwell, the United Kingdom.

TC BioPharm (Holdings) plc - ADR

No change

25 bps cut

25 bps hike

Note sure, just watching

The Fed announces its rate decision this Wednesday.

Markets are pricing in a ~99% chance of no change at this week’s Fed decision, according to prediction markets. $SPY $QQQ 

FOMC on Wednesday, what do you think the Fed will decide?

TCBP
TC BioPharm Holdings Ltd

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest TCBP News

TCBPTC BioPharm Holdings Ltd